| Net Cash Provided by (Used in) Operating Activities |
$286,000,000 |
USD |
-158% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$163,000,000 |
USD |
-527% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$36,000,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
375,000,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
152,047,739 |
shares |
-10% |
Q4 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$396,000,000 |
USD |
-115% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$2,135,000,000 |
USD |
-25% |
Q4 2025 |
FY 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$19,000,000 |
USD |
-5% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$1,179,000,000 |
USD |
-5% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$1,473,000,000 |
USD |
0% |
Q4 2025 |
FY 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$11,000,000 |
USD |
-68% |
Q1 2025 |
Q1 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$34,000,000 |
USD |
-98% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$397,000,000 |
USD |
9.7% |
Q4 2025 |
FY 2025 |
| Unrecognized Tax Benefits |
$31,000,000 |
USD |
-6.1% |
Q4 2025 |
FY 2025 |
| Depreciation, Depletion and Amortization |
$18,000,000 |
USD |
0% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$294,000,000 |
USD |
27% |
Q4 2025 |
FY 2025 |
| Interest Expense |
$49,000,000 |
USD |
-21% |
Q3 2024 |
Q3 2024 |